Harvard Medical School

by Harvard Medical School  · Based in United States → — AI in Clinical Medicine
Anesthesiology Cardiology critical-care-medicine

$1,200 - $2,500
Documentation ProvidedRegulatory Status Disclosed

Overview

Harvard Medical School (HMS) offers an “AI in Clinical Medicine” course designed to educate healthcare professionals on the applications and implications of artificial intelligence in medical practice. The course is primarily for physicians, nurses, advanced practice providers, and other allied health professionals who seek to understand how AI is transforming medical care.

  • What it does: The course provides foundational principles of AI and explores its applications in diagnosing diseases, predicting patient outcomes, patient monitoring, and personalizing treatment plans. It also delves into ethical considerations, challenges, and opportunities related to AI integration in healthcare.
  • Who it is for: It targets clinicians and healthcare professionals across various specialties and care settings, including those in hospitals, clinics, and primary care systems.
  • How it fits a clinical or practice workflow: The program aims to equip participants with practical skills and insights to apply AI technologies in clinical medicine. It covers strategies for integrating AI into clinical organizations and practices, including workflow assessment, system engineering, accuracy evaluation, model selection, and change management. AI tools can assist in automating routine tasks like medical scribing, interpreting imaging results, and supporting clinical decision-making by providing data and expertise.
  • Notable capabilities: The course emphasizes real-world case studies and expert-led sessions to provide firsthand viewpoints on AI’s potential in clinical practice. It also addresses the regulatory landscape of AI in medicine. HMS also offers other AI-focused learning opportunities, including a PhD program in AI in Medicine and courses on AI in healthcare for medical students.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Comprehensive AI fundamentals
  • Clinical application case studies
  • Ethical and regulatory discussions
  • CME credits
  • Expert faculty instruction
  • Future trends in medical AI

Use Cases

  • Educating physicians on AI in medicine
  • Understanding AI's impact on diagnostics
  • Learning about AI in treatment planning
  • Exploring ethical considerations of AI in healthcare
  • Staying current with medical technology advancements

What Physicians Need to Know

Evidence Base (guidelines, literature scope)
The Harvard Medical School's 'AI in Clinical Medicine' course emphasizes understanding how AI systems detect patterns, learn from data, and generate predictions that support clinical reasoning. It covers how AI analyzes medical images, lab results, and patient records for diagnosis and explores how predictive models and clinical decision-support tools aid in tailoring treatment plans. The curriculum also delves into how AI identifies patterns in large-scale biological data for disease mechanisms and drug discovery.
Clinical Validation Studies
The course examines the ethical and regulatory challenges in evaluating AI tools in healthcare, including the importance of assessing their long-term quality and accuracy. A joint Stanford-Harvard 'State of Clinical AI 2026' report highlights that while over 1,200 AI-enabled medical devices have been cleared by the FDA, less than 15% are routinely used in hospitals, indicating a 'deployment gap'. The report also notes that impressive results in narrow research settings often depend on how narrowly the problem is framed, and that real-world performance requires testing early in the patient course when clinical data is sparse. There's a call for rigorous, prospective clinical trials in real care settings to evaluate AI tools.
Alert Fatigue Management
While not explicitly detailed as 'alert fatigue management' for a specific tool, the course content addresses the broader challenges and limitations of AI tools, including potential biases and data limitations that can affect reliability. The 'State of Clinical AI 2026' report mentions that poor interface design can lead to hospital-approved tools sitting unused, which indirectly relates to usability and potential for alert fatigue if systems are not well-integrated.
Drug Interaction Checking
The course explores how AI informs therapy selection and guides medication management, suggesting an understanding of AI's role in optimizing drug-related decisions. One of the programs also mentions that AI and deep learning algorithms are being used to identify secondary uses of medications and instances where medications might be causing harm.
Differential Diagnosis Support
The curriculum explicitly covers how AI analyzes medical images, lab results, and patient records to identify patterns and support clinical diagnosis and diagnostic reasoning. It also explores how AI systems detect patterns in data and turn them into predictions that support clinical reasoning.
Guideline Update Frequency
The 'State of Clinical AI 2026' report highlights a phenomenon called 'clinical drift,' where AI models' accuracy can degrade due to changes in hospital protocols, patient demographics, and evolving viruses if the models are not updated to match new realities. This implicitly emphasizes the need for frequent updates to AI models and, by extension, the guidelines they might be based on or inform.
Clinical Workflow Integration
The course focuses on how AI tools enhance diagnosis and treatment while streamlining clinical documentation and improving workflow efficiency. A related program, 'Implementing AI in Clinical Practice,' specifically equips clinicians with skills to design effective implementation strategies, including workflow assessment and system engineering to identify tasks for automation and structured operational sequences. It also covers change management for preparing teams and systems for AI-led workflows.
Decision Audit Trail
The course examines the ethical challenges of bias, privacy, and transparency shaping how AI tools are evaluated in healthcare. A proposed conceptual framework for integrating AI into clinical training, inspired by Harvard Medical School's course, emphasizes embedding ethics to address bias and patient autonomy. While not explicitly mentioning 'decision audit trail,' the focus on transparency and accountability suggests an underlying need for understanding and tracing AI's decision-making processes.
Physician Tip

Physicians should focus on developing 'AI literacy' to understand how AI systems work, their applications, and their limitations, especially regarding bias, privacy, and patient trust. It's crucial to recognize that AI tools are meant to support, not replace, clinical judgment. Be aware of the 'deployment gap' where many FDA-cleared AI tools are not routinely used due to integration challenges, and advocate for user-friendly interfaces. Understand that AI models can experience 'clinical drift' and require continuous evaluation and updates to remain accurate in evolving clinical realities. Actively engage in understanding the ethical implications and potential biases of AI algorithms in patient care, diagnosis, and treatment planning.

The Harvard Medical School's AI in Clinical Medicine course and related programs highlight the importance of integrating AI into existing clinical workflows and health systems. This includes assessing current workflows to identify areas for AI-driven improvement, designing new AI-enhanced workflows, and managing the change process. The curriculum also touches upon the regulatory landscape for AI in medicine, which is critical for successful integration. The 'State of Clinical AI 2026' report underscores the challenge of integrating AI tools effectively, noting that many tools sit unused due to poor interface design, suggesting that seamless integration into existing IT infrastructure and user experience are key for successful adoption.

Details

Category Clinical Decision Support & Reference, Medical Education & Training
Pricing $1,200 - $2,500
  • The three-day online course is $2,500
  • Attendees can register for the first two days only for $1,900 or the last day only for $1,200
Free Trial No
DeploymentOnline
Mobile App1
API Available No
LanguagesEnglish
TrainingUnknown
Compliance
BAA AvailableUnknown AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Not applicable AI-estimated — unknown
Integrations
EHR Not specified
Specialties Anesthesiology, Cardiology, Critical Care Medicine, Dermatology, Emergency Medicine, Endocrinology, Family Medicine, Gastroenterology, General Surgery, Geriatrics, Infectious Disease, Internal Medicine, Nephrology, Neurology, Oncology, Ophthalmology, Orthopedics, Pathology, Pediatrics, Physical Medicine Rehabilitation, Preventive Medicine, Psychiatry, Pulmonology, Radiology, Rheumatology, Urology

Social Proof

Customersunknown
Notable
Physicians and healthcare professionals worldwide

Support & Reliability

Training ProvidedUnknown

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Harvard Medical School

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Harvard Medical School.

View all on YouTube

Frequently Asked Questions

Harvard Medical School (HMS) emphasizes evidence-based medicine and integrates various CDS principles into its curriculum. While HMS doesn't endorse a single proprietary CDS tool, its affiliated hospitals and research often utilize systems like Epic's embedded CDS, UpToDate, or other point-of-care resources. The focus is on critical appraisal of information and understanding the methodologies behind CDS rather than promoting a specific vendor.
HMS acknowledges the challenges of alert fatigue and physician compliance with CDS. Its educational approaches often highlight the importance of well-designed CDS that minimizes irrelevant alerts and integrates seamlessly into workflows. Research at HMS and its affiliates frequently explores optimizing CDS to improve usability and reduce cognitive burden, emphasizing the need for intelligent and context-aware systems.
While HMS doesn't officially endorse specific open-source CDS tools, many faculty and researchers are involved in initiatives that promote equitable access to medical knowledge. Discussions around open-source alternatives often occur in the context of global health and efforts to develop sustainable healthcare solutions, though direct advocacy for particular platforms would depend on individual research or departmental focus.
The pricing models for advanced CDS resources vary widely and are typically determined by the vendors themselves, not directly by HMS. Access to many commercial CDS tools is often provided through institutional subscriptions at HMS-affiliated hospitals or individual professional licenses. HMS's role is more in evaluating the efficacy and utility of such tools rather than managing their commercial aspects.
HMS experts recognize several limitations in current CDS technologies, including challenges with integrating diverse data sources, ensuring diagnostic accuracy across varied patient populations, and fully supporting personalized medicine. There's ongoing research into improving CDS to account for individual patient variability, address biases in algorithms, and enhance their ability to support complex clinical reasoning rather than simply providing alerts.
HMS and its affiliated hospitals frequently offer CME programs that touch upon health informatics, digital health, and the effective use of technology in clinical practice, which often include components on clinical decision support. These programs aim to equip physicians with the skills to critically evaluate, implement, and optimize CDS tools to enhance patient care and safety.
HMS and its affiliated research institutions are at the forefront of developing new CDS functionalities, particularly those leveraging AI and machine learning for predictive analytics, risk stratification, and personalized treatment recommendations. Numerous research groups are actively exploring how these advanced technologies can be integrated into CDS to improve diagnostic capabilities, predict disease progression, and optimize therapeutic interventions.

Related Tools

Cortex
Cortex
Clinical Decision Support & Reference
Cortex Workspace is a secure, HIPAA-compliant AI platform designed to streamline healthcare workflows and enhance decision-making for physicians.
SureMediks ProView
SureMediks (Rasimo Systems, LLC)
Clinical Decision Support & Reference
SureMediks is an AI-powered clinical decision support and metabolic health platform that automates care workflows for specialists, providing AI-generated patient summaries, automated chart review, and real-time biometric alerts.
SOAP Health
SOAP Health
Clinical Decision Support & Reference
SOAP Health is a Florida-based startup transforming patient intake with AI-powered diagnosis, offering a comprehensive solution that improves diagnosis accuracy and empowers patients and physicians.
Oxipit ChestLink
Oxipit (part of Sectra group)
Clinical Decision Support & Reference
Oxipit ChestLink is the world's first CE Class IIb-certified autonomous AI application for healthy chest X-ray reporting, capable of identifying normal studies with 99.9% sensitivity. It automates the reporting of normal chest X-rays, reducing radiologist workload and improving efficiency.
KATE AI
Mednition
Clinical Decision Support & Reference
KATE AI is a nurse-built clinical decision support tool for emergency departments that analyzes incoming patients in real-time to flag high-risk cases that standard acuity scoring might miss. It has supported over 5,000,000 patient visits, helping emergency teams deliver safer, faster, and more informed care.
MCG Health
MCG Health
Clinical Decision Support & Reference
MCG Health provides industry-leading evidence-based guidance and technologies to optimize health outcomes, drive operational efficiency, and achieve cost savings. Their solutions are utilized by thousands of hospitals, a majority of U.S. health plans, and various government health programs.

See all Clinical Decision Support & Reference tools →

Suggest an Edit → | Last Verified: 2026-07-03 | First Added: 2026-06-21
AI Tool Finder
AI-powered search. Results may not be comprehensive.